Skip to main content
Erschienen in: Discover Oncology 1/2010

01.02.2010

Trends in Distant-Stage Breast, Colorectal, and Prostate Cancer Incidence Rates from 1992 to 2004: Potential Influences of Screening and Hormonal Factors

verfasst von: Jean A. McDougall, Christopher I. Li

Erschienen in: Discover Oncology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Differential utilization of cancer screening between populations could lead to changes in cancer disparities. Evaluating incidence rates trends is one means of monitoring these disparities. Using Surveillance, Epidemiology, and End Results data, we compared annual percent changes (APC) in age-adjusted incidence rates of distant-stage breast, colorectal, and prostate cancer between non-Hispanic whites (NHW) and African Americans (AA). From 1992 to 2004, distant-stage breast cancer incidence rates remained essentially constant among both AA and NHW women, though rates were 30–90% higher among AA women throughout. NHW men and women experienced declines in distant-stage colorectal cancer incidence rates [APC = −1.6, 95% confidence interval (CI) −2.3, −0.9], but AA men and women did not. Distant-stage prostate cancer incidence rates declined for both AA (APC = −5.8, 95% CI −7.9, −3.8) and NHW (APC = −5.1, 95% CI −6.7, -3.4). Despite now having nearly equal mammography screening rates, the persistent breast cancer disparity observed among AAs compared to NHWs may be due to the greater susceptibility of AAs to more aggressive tumors, particularly hormone-receptor-negative disease, which is more difficult to detect by mammography. For colorectal cancer, greater utilization of screening tests among NHWs vs. AAs is likely a primary contributor to the observed widening disparity. Wider recognition of AA race as a prostate cancer risk factor may contribute to the narrowing disparity in the incidence of disease.
Literatur
1.
Zurück zum Zitat Boyer-Chammard A, Taylor TH, Anton-Culver H (1999) Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev 23(6):463–473CrossRefPubMed Boyer-Chammard A, Taylor TH, Anton-Culver H (1999) Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev 23(6):463–473CrossRefPubMed
2.
Zurück zum Zitat Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94(7):490–496PubMed Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94(7):490–496PubMed
3.
Zurück zum Zitat Joslyn SA, West MM (2000) Racial differences in breast carcinoma survival. Cancer 88(1):114–123CrossRefPubMed Joslyn SA, West MM (2000) Racial differences in breast carcinoma survival. Cancer 88(1):114–123CrossRefPubMed
4.
Zurück zum Zitat Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97(1):134–147CrossRefPubMed Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97(1):134–147CrossRefPubMed
5.
Zurück zum Zitat Cress RD, Morris CR, Wolfe BM (2000) Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med 31(4):447–453CrossRefPubMed Cress RD, Morris CR, Wolfe BM (2000) Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med 31(4):447–453CrossRefPubMed
6.
Zurück zum Zitat Chu KC, Tarone RE, Freeman HP (2003) Trends in prostate cancer mortality among black men and white men in the United States. Cancer 97(6):1507–1516CrossRefPubMed Chu KC, Tarone RE, Freeman HP (2003) Trends in prostate cancer mortality among black men and white men in the United States. Cancer 97(6):1507–1516CrossRefPubMed
7.
Zurück zum Zitat Merrill RM, Lyon JL (2000) Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology 55(5):730–735CrossRefPubMed Merrill RM, Lyon JL (2000) Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology 55(5):730–735CrossRefPubMed
8.
Zurück zum Zitat Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Soler-Vila H et al (2008) Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev 17(10):2825–2834CrossRefPubMed Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Soler-Vila H et al (2008) Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev 17(10):2825–2834CrossRefPubMed
9.
Zurück zum Zitat Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86(9):705–712CrossRefPubMed Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86(9):705–712CrossRefPubMed
10.
Zurück zum Zitat Elmore JG, Moceri VM, Carter D, Larson EB (1998) Breast carcinoma tumor characteristics in black and white women. Cancer 83(12):2509–2515CrossRefPubMed Elmore JG, Moceri VM, Carter D, Larson EB (1998) Breast carcinoma tumor characteristics in black and white women. Cancer 83(12):2509–2515CrossRefPubMed
11.
Zurück zum Zitat Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11(7):601–607PubMed Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11(7):601–607PubMed
12.
Zurück zum Zitat Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502CrossRefPubMed Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502CrossRefPubMed
13.
Zurück zum Zitat Powell IJ, Banerjee M, Sakr W, Grignon D, Wood DP Jr, Novallo M et al (1999) Should African–American men be tested for prostate carcinoma at an earlier age than white men? Cancer 85(2):472–477CrossRefPubMed Powell IJ, Banerjee M, Sakr W, Grignon D, Wood DP Jr, Novallo M et al (1999) Should African–American men be tested for prostate carcinoma at an earlier age than white men? Cancer 85(2):472–477CrossRefPubMed
14.
Zurück zum Zitat Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9(1):R6CrossRefPubMed Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9(1):R6CrossRefPubMed
15.
Zurück zum Zitat Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA et al (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91(23):2020–2028CrossRefPubMed Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA et al (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91(23):2020–2028CrossRefPubMed
16.
Zurück zum Zitat Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE et al (2005) A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 14(5):1108–1112CrossRefPubMed Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE et al (2005) A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 14(5):1108–1112CrossRefPubMed
17.
Zurück zum Zitat Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G et al (2009) Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiol Biomarkers Prev 18(5):1484–1491CrossRefPubMed Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G et al (2009) Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiol Biomarkers Prev 18(5):1484–1491CrossRefPubMed
18.
Zurück zum Zitat Winters SJ, Brufsky A, Weissfeld J, Trump DL, Dyky MA, Hadeed V (2001) Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 50(10):1242–1247CrossRefPubMed Winters SJ, Brufsky A, Weissfeld J, Trump DL, Dyky MA, Hadeed V (2001) Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 50(10):1242–1247CrossRefPubMed
19.
Zurück zum Zitat Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW et al (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89(2):166–170CrossRefPubMed Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW et al (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89(2):166–170CrossRefPubMed
20.
Zurück zum Zitat Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H et al (1998) Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 58(20):4497–4504PubMed Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H et al (1998) Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 58(20):4497–4504PubMed
21.
Zurück zum Zitat Travis RC, Schumacher F, Hirschhorn JN, Kraft P, Allen NE, Albanes D et al (2009) CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 18(10):2734–2744CrossRefPubMed Travis RC, Schumacher F, Hirschhorn JN, Kraft P, Allen NE, Albanes D et al (2009) CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 18(10):2734–2744CrossRefPubMed
22.
Zurück zum Zitat Ries LAG, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (eds) (2008) SEER cancer statistics review, 1975–2005. National Cancer Institute, Bethesda Ries LAG, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (eds) (2008) SEER cancer statistics review, 1975–2005. National Cancer Institute, Bethesda
23.
Zurück zum Zitat Young J, Roffers S, Ries L, Fritz A, Hurlbut A (2001) SEER summary staging manual—2000: codes and coding instructions. National Cancer Institute, Bethesda Young J, Roffers S, Ries L, Fritz A, Hurlbut A (2001) SEER summary staging manual—2000: codes and coding instructions. National Cancer Institute, Bethesda
24.
Zurück zum Zitat Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351CrossRefPubMed
25.
Zurück zum Zitat Harper S, Lynch J (2005) Methods for measuring cancer disparities: a review using data relevant to healthy people 2010 cancer-related objectives. National Institutes of Health, Bethesda Harper S, Lynch J (2005) Methods for measuring cancer disparities: a review using data relevant to healthy people 2010 cancer-related objectives. National Institutes of Health, Bethesda
26.
Zurück zum Zitat Anderson WF, Reiner AS, Matsuno RK, Pfeiffer RM (2007) Shifting breast cancer trends in the United States. J Clin Oncol 25(25):3923–3929CrossRefPubMed Anderson WF, Reiner AS, Matsuno RK, Pfeiffer RM (2007) Shifting breast cancer trends in the United States. J Clin Oncol 25(25):3923–3929CrossRefPubMed
27.
Zurück zum Zitat Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56(3):168–183CrossRefPubMed Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56(3):168–183CrossRefPubMed
28.
Zurück zum Zitat Swan J, Breen N, Coates RJ, Rimer BK, Lee NC (2003) Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 97(6):1528–1540CrossRefPubMed Swan J, Breen N, Coates RJ, Rimer BK, Lee NC (2003) Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 97(6):1528–1540CrossRefPubMed
29.
Zurück zum Zitat Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA (2004) Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 101(7):1490–1500CrossRefPubMed Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA (2004) Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 101(7):1490–1500CrossRefPubMed
30.
Zurück zum Zitat Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA et al (2003) Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50–64 years. Cancer Epidemiol Biomarkers Prev 12(11 Pt 1):1175–1181PubMed Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA et al (2003) Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50–64 years. Cancer Epidemiol Biomarkers Prev 12(11 Pt 1):1175–1181PubMed
31.
Zurück zum Zitat Chu KC, Tarone RE, Chow WH, Alexander GA (1995) Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch Fam Med 4(10):849–856CrossRefPubMed Chu KC, Tarone RE, Chow WH, Alexander GA (1995) Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch Fam Med 4(10):849–856CrossRefPubMed
32.
Zurück zum Zitat Drake BF, Lathan CS, Okechukwu CA, Bennett GG (2008) Racial differences in prostate cancer screening by family history. Ann Epidemiol 18(7):579–583CrossRefPubMed Drake BF, Lathan CS, Okechukwu CA, Bennett GG (2008) Racial differences in prostate cancer screening by family history. Ann Epidemiol 18(7):579–583CrossRefPubMed
33.
Zurück zum Zitat Wingo PA, Jamison PM, Hiatt RA, Weir HK, Gargiullo PM, Hutton M et al (2003) Building the infrastructure for nationwide cancer surveillance and control—a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control 14(2):175–193CrossRefPubMed Wingo PA, Jamison PM, Hiatt RA, Weir HK, Gargiullo PM, Hutton M et al (2003) Building the infrastructure for nationwide cancer surveillance and control—a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control 14(2):175–193CrossRefPubMed
34.
Zurück zum Zitat Clegg LX, Reichman ME, Hankey BF, Miller BA, Lin YD, Johnson NJ et al (2007) Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 18(2):177–187CrossRefPubMed Clegg LX, Reichman ME, Hankey BF, Miller BA, Lin YD, Johnson NJ et al (2007) Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 18(2):177–187CrossRefPubMed
Metadaten
Titel
Trends in Distant-Stage Breast, Colorectal, and Prostate Cancer Incidence Rates from 1992 to 2004: Potential Influences of Screening and Hormonal Factors
verfasst von
Jean A. McDougall
Christopher I. Li
Publikationsdatum
01.02.2010
Verlag
Springer-Verlag
Erschienen in
Discover Oncology / Ausgabe 1/2010
Print ISSN: 1868-8497
Elektronische ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-009-0002-1

Weitere Artikel der Ausgabe 1/2010

Discover Oncology 1/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.